QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (Nasdaq:ANGO) announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Oncobionic, Inc. to market Irreversible Electroporation (IRE) – a technology indicated for surgical ablation of soft tissue, including cardiac and smooth muscle.
